NORMAL SITUATION

ViroVet

Export PDF

Financial year 2026 · closed on 25/06/2026

Net result

-238,9 k €

+83.7% YoY

Equity

-3,6 M €

-7.2% YoY

Company — Normal situation.

Strike-off: 19 août 2026

What does ViroVet do?

ViroVet is a Public limited company incorporated in 2015.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0634.891.328

Incorporation

06/08/2015

Legal form

Public limited company

Contributed capital

6 009 838,00 €

Latest accounts

25/06/2026

Joint committees (1)

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 11 financial years

	2026		2025		2024		2023		2022		2021		2020		2019		2018		2017		2016
Income statement
Revenue	–		–		–		–		–		12,7 k €	-87.5%	101,4 k €	-74.5%	397 k €	+98.7%	199,8 k €	+64.5%	121,5 k €	+46.4%	83 k €
EBITDA	-60,5 k €	+91.6%	-721,2 k €	+55.5%	-1,6 M €	-1.0%	-1,6 M €	-6.7%	-1,5 M €	+0.7%	-1,5 M €	-0.4%	-1,5 M €	-136%	-640,4 k €	-11.4%	-574,9 k €	-10.8%	-519 k €	+13.0%	-596,2 k €
Operating result	-64,7 k €	+94.3%	-1,1 M €	+54.9%	-2,5 M €	+4.7%	-2,6 M €	+0.2%	-2,6 M €	+1.2%	-2,7 M €	+2.5%	-2,7 M €	-23.0%	-2,2 M €	-10.9%	-2 M €	-50.8%	-1,3 M €	-122%	-598,2 k €
Net result	-238,9 k €	+83.7%	-1,5 M €	+45.4%	-2,7 M €	-3.3%	-2,6 M €	+0.2%	-2,6 M €	+1.3%	-2,6 M €	+5.6%	-2,8 M €	-28.7%	-2,2 M €	-11.2%	-1,9 M €	-53.9%	-1,3 M €	-101%	-628,8 k €
Balance sheet
Equity	-3,6 M €	-7.2%	-3,3 M €	-78.5%	-1,9 M €	-328%	816,3 k €	-57.3%	1,9 M €	-4.9%	2 M €	-56.7%	4,6 M €	+247%	1,3 M €	-61.8%	3,5 M €	+42.9%	2,5 M €	-17.4%	3 M €
Total assets	168,5 k €	-39.1%	276,5 k €	-84.6%	1,8 M €	-23.5%	2,3 M €	-6.2%	2,5 M €	+3.4%	2,4 M €	-52.0%	5 M €	+184%	1,8 M €	-57.4%	4,2 M €	+51.1%	2,8 M €	-19.9%	3,4 M €
Cash	7,1 k €	-89.4%	67,3 k €	-93.5%	1 M €	-33.2%	1,6 M €	+18.3%	1,3 M €	-5.3%	1,4 M €	-64.5%	3,9 M €	+880%	400,1 k €	-85.7%	2,8 M €	+65.2%	1,7 M €	-23.3%	2,2 M €
Debts	3 M €	-1.4%	3 M €	-11.4%	3,4 M €	+125%	1,5 M €	+160%	588,9 k €	+44.4%	407,8 k €	+16.4%	350,4 k €	-7.4%	378,3 k €	-19.7%	471,1 k €	+119%	215,4 k €	-52.2%	450,9 k €
Other
Workforce	–		3,8 ETP	-64.8%	10,8 ETP	-4.4%	11,3 ETP	-18.1%	13,8 ETP	+3.8%	13,3 ETP	+4.7%	12,7 ETP	+2.4%	12,4 ETP	+17.0%	10,6 ETP	+34.2%	7,9 ETP	+83.7%	4,3 ETP

Governance

Board of directors

Seen on filing of 25/06/2026 · 6 active · 29 ended

Active mandates

VIVES PARTNERS

Director · since 31 janvier 2024 · until 25 juin 2026 · 1004.227.835

Represented by Yannick Vancoppenolle

Active

Patrik Haesen

Director · since 30 septembre 2021 · until 25 juin 2026

Active

Ilse Sienaert

Director · since 06 juin 2020 · until 25 juin 2026

Active

BIOTECH FONDS VLAANDEREN

Director · since 28 mai 2020 · until 25 juin 2026 · 0454.215.168

Represented by Thomas Beke

Active

CAPRICORN PARTNERS

Director · since 28 mai 2020 · until 25 juin 2026 · 0449.330.922

Represented by Ludwig Goris

Active

ESBEE

Managing director · since 28 mai 2020 · until 25 juin 2026 · 0479.439.425

Represented by Erwin Blomsma

Active

Ended mandates

VIVES PARTNERS

Director · since 31 janvier 2024 · until 27 mai 2026 · 1004.227.835

Represented by Yannick Vancoppenolle

Ended

Patrik Haesen

Director · since 30 septembre 2021 · until 29 septembre 2027

Ended

Ilse Sienaert

Director · since 06 juin 2020 · until 05 juin 2026

Ended

BIOTECH FONDS VLAANDEREN

Director · since 28 mai 2020 · until 27 mai 2026 · 0454.215.168

Represented by Filip Goossens

Ended

Annual accounts

Full financial information

	2026	2025	2024	2023	2022	2021
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2026	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021
Closing of the financial year	25/06/2026	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021
Length of the financial year	6 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/06/2026	30/06/2026	01/07/2025	27/05/2024	24/05/2023	16/06/2022
General meeting	25/06/2026	25/06/2026	30/06/2025	24/05/2024	19/05/2023	15/06/2022
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

11 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	25/06/2026	25/06/2026	30/06/2026	Dutch	PDF
Full model	31/12/2025	25/06/2026	30/06/2026	Dutch	PDF
Full model	31/12/2024	30/06/2025	01/07/2025	Dutch	PDF
Full model	31/12/2023	24/05/2024	27/05/2024	Dutch	PDF
Full model	31/12/2022	19/05/2023	24/05/2023	Dutch	PDF
Full model	31/12/2021	15/06/2022	16/06/2022	Dutch	PDF
Full model	31/12/2020	21/05/2021	07/06/2021	Dutch	PDF
Full model	31/12/2019	22/05/2020	26/05/2020	Dutch	PDF
Full model	31/12/2018	24/05/2019	28/05/2019	Dutch	PDF
Full model	31/12/2017	18/05/2018	31/05/2018	Dutch	PDF
Full model	31/12/2016	19/05/2017	22/05/2017	Dutch	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 25/06/2026 · 6 active · 29 ended

Active mandates

VIVES PARTNERS

Director · since 31 janvier 2024 · until 25 juin 2026 · 1004.227.835

Represented by Yannick Vancoppenolle

Active

Patrik Haesen

Director · since 30 septembre 2021 · until 25 juin 2026

Active

Ilse Sienaert

Director · since 06 juin 2020 · until 25 juin 2026

Active

BIOTECH FONDS VLAANDEREN

Director · since 28 mai 2020 · until 25 juin 2026 · 0454.215.168

Represented by Thomas Beke

Active

CAPRICORN PARTNERS

Director · since 28 mai 2020 · until 25 juin 2026 · 0449.330.922

Represented by Ludwig Goris

Active

ESBEE

Managing director · since 28 mai 2020 · until 25 juin 2026 · 0479.439.425

Represented by Erwin Blomsma

Active

Ended mandates

VIVES PARTNERS

Director · since 31 janvier 2024 · until 27 mai 2026 · 1004.227.835

Represented by Yannick Vancoppenolle

Ended

Patrik Haesen

Director · since 30 septembre 2021 · until 29 septembre 2027

Ended

Ilse Sienaert

Director · since 06 juin 2020 · until 05 juin 2026

Ended

BIOTECH FONDS VLAANDEREN

Director · since 28 mai 2020 · until 27 mai 2026 · 0454.215.168

Represented by Filip Goossens

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Annual accounts27/08/2026
GOEDKEURING VAN DE (VERKORTE) JAARREKENING — KWIJTINGEN -
PDF
Mandates23/03/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/01/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/06/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/02/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/06/2023
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares20/04/2023
KAPITAAL - AANDELEN
PDF
Capital / shares23/06/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2026
Annual accounts 2026-238,9 k €↑
2025
Annual accounts 2025-1,5 M €↑
2024
Annual accounts 2024-2,7 M €↓
2023
Annual accounts 2023-2,6 M €↑
2022
Annual accounts 2022-2,6 M €↑
2021
Annual accounts 2021-2,6 M €↑
2020
Annual accounts 2020-2,8 M €↓
2019
Annual accounts 2019-2,2 M €↓
2018
Annual accounts 2018-1,9 M €↓
2017
Annual accounts 2017-1,3 M €↓
2016
Annual accounts 2016-628,8 k €
06/08/2015
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ViroVet

Overview

What does ViroVet do?

Trend over 11 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline